Literature DB >> 8478405

Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies.

B Barbiroli1, P Montagna, P Martinelli, R Lodi, S Iotti, P Cortelli, R Funicello, P Zaniol.   

Abstract

We studied brain energy metabolism by phosphorus magnetic resonance spectroscopy (31P MRS) in 28 patients with mitochondrial cytopathies, and 20 normal control subjects. Fourteen patients had myopathy alone, six had only mild brain symptoms, and eight showed different degrees of brain involvement. Brain 31P MRS showed a low phosphocreatine content in all patients, accompanied by a high inorganic phosphate in 14 of 28 patients. The average value of the Pi concentration in the patient group was significantly (p = 0.009) different from the control group. The cytosolic pH was normal. From these data were derived a high concentration of ADP (calculated from the creatine kinase equilibrium), a high percent value of V/Vmax for ATP biosynthesis, and a low phosphorylation potential, all features showing a derangement of brain energy metabolism, in all patients with mitochondrial cytopathies. 31P MRS proved to be sensitive enough to disclose a deficit of mitochondrial functionality not only in the affected patients, but also in those without clinically evident brain symptoms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478405     DOI: 10.1038/jcbfm.1993.61

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  18 in total

1.  Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

Authors:  K Yonemura; Y Hasegawa; K Kimura; K Minematsu; T Yamaguchi
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  Effect of altitude on brain intracellular pH and inorganic phosphate levels.

Authors:  Xian-Feng Shi; Paul J Carlson; Tae-Suk Kim; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Seong-Eun Kim; Breanna Glaeser; Kristina Wang; Chun S Zuo; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  Psychiatry Res       Date:  2014-04-13       Impact factor: 3.222

Review 3.  Brain and skeletal muscle bioenergetic failure in familial hypobetalipoproteinaemia.

Authors:  R Lodi; R Rinaldi; A Gaddi; S Iotti; R D'Alessandro; N Scoz; M Battino; V Carelli; G Azzimondi; P Zaniol; B Barbiroli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

4.  In vivo assessment of human skeletal muscle mitochondria respiration in health and disease.

Authors:  B Barbiroli; S Iotti; R Lodi
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

Review 5.  Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

Authors:  Tadafumi Kato
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 6.  A possible role for mitochondrial dysfunction in migraine.

Authors:  S Stuart; L R Griffiths
Journal:  Mol Genet Genomics       Date:  2012-10-07       Impact factor: 3.291

Review 7.  Energy failure in multiple sclerosis and its investigation using MR techniques.

Authors:  David Paling; Xavier Golay; Claudia Wheeler-Kingshott; Raju Kapoor; David Miller
Journal:  J Neurol       Date:  2011-06-10       Impact factor: 4.849

8.  Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy.

Authors:  B Barbiroli; R Medori; H J Tritschler; T Klopstock; P Seibel; H Reichmann; S Iotti; R Lodi; P Zaniol
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

Review 9.  Neuroimaging of mitochondrial disease.

Authors:  Russell P Saneto; Seth D Friedman; Dennis W W Shaw
Journal:  Mitochondrion       Date:  2008-05-23       Impact factor: 4.160

10.  (31)P CSI of the human brain in healthy subjects and tumor patients at 9.4 T with a three-layered multi-nuclear coil: initial results.

Authors:  Christian Mirkes; Gunamony Shajan; Grzegorz Chadzynski; Kai Buckenmaier; Benjamin Bender; Klaus Scheffler
Journal:  MAGMA       Date:  2016-01-25       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.